First COVID Treatment Pill Approved in the UK

You are viewing content from Ireland's Classic Hits Radio Galway. Would you like to make this your preferred location?

The first anti-viral pill created for treatment of COVID-19 has been approved for use in the UK.

The drug, Molnupiravir, will be offered to those who have received a positive test and are at risk of developing severe illness due to factors like obesity, diabetes, heart disease or being over 60.

Molnupiravir interferes with the virus's replication, preventing it from multiplying and thus reducing the impact of the disease.

The UK's Medicines and Healthcare products Regulatory Agency (MHRA) claims the pill is safe and is effective in reducing the need for hospitalisation. It also greatly reduces the risk of death in those high risk patients with mild to moderate COVID. It should be taken within five days of a positive test result in order to be effective.

The news comes amid the release of data that shows last month saw COVID cases rise to their highest level in the UK since the beginning of the pandemic.

Cases have been particularly high among children, with 6% of the UK's children having had COVID. 

UK health authorities are also concerned with the rise in cases among older groups.

"We did see a doubling in that group, and clearly that's the worry," said epidemiologist Paul Elliott. "It's being driven from the young school age but it is going right across the whole population."

More from Dublin News

  • Ireland's Classic Hits Records Third Successive All-Time Listenership High

    Ireland's Classic Hits Radio has recorded its third successive JNLR all time high in the latest JNLR. The ratings, which cover the period May-December 2021, give the multicity broadcaster 321,000 weekly and 161,000 daily listeners, increases from 309,000 and 158,000 respectively on the last JNLR survey. Market share now stands at 5.2% in the multicity area. *